NeoGenomics, Inc.
US ˙ NasdaqCM ˙ US64049M2098

SecurityNEO / NeoGenomics, Inc.
InsiderLawrence Martin Weiss
This page shows the track record and history of Weiss Lawrence Martin insider trades in NeoGenomics, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Lawrence Martin Weiss in NEO / NeoGenomics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

NEO / NeoGenomics, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Lawrence Martin Weiss in NEO / NeoGenomics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2020-12-14 20,200 51.0600 20,200 51.0600 1,031,412 354 30.49 -415,514 -40.29

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

NEO / NeoGenomics, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2021-04-26 2021-04-22 4 Weiss Lawrence Martin NEO Stock Option (Right to Buy) M - Exercise D 28.33 -9,378 28,136
2021-04-26 2021-04-22 4 Weiss Lawrence Martin NEO Stock Option (Right to Buy) M - Exercise D 19.60 -9,005 18,012
2021-04-26 2021-04-22 4 Weiss Lawrence Martin NEO Stock Option (Right to Buy) M - Exercise D 9.22 -6,667 0
2021-04-26 2021-04-22 4 Weiss Lawrence Martin NEO Common Stock M - Exercise D 28.3300 9,378 266 130,847
2021-04-26 2021-04-22 4 Weiss Lawrence Martin NEO Common Stock M - Exercise D 19.6000 9,005 176 121,469
2021-04-26 2021-04-22 4 Weiss Lawrence Martin NEO Common Stock M - Exercise D 9.2200 6,667 61 112,464
2021-03-03 2021-03-02 4 Weiss Lawrence Martin NEO Stock Option (Right to Buy) A - Award D 53.17 53.1700 29,895 1,590 29,895
2021-03-03 2021-03-02 4 Weiss Lawrence Martin NEO Common Stock A - Award D 5,276 105,797
2020-12-15 2020-12-14 4 Weiss Lawrence Martin NEO Stock Option (Right to Buy) M - Exercise D 19.60 -9,005 27,017
2020-12-15 2020-12-14 4 Weiss Lawrence Martin NEO Stock Option (Right to Buy) M - Exercise D 13.87 -16,666 8,334
2020-12-15 2020-12-14 4 Weiss Lawrence Martin NEO Stock Option (Right to Buy) M - Exercise D 9.22 -13,333 6,667
2020-12-15 2020-12-14 4 Weiss Lawrence Martin NEO Stock Option (Right to Buy) M - Exercise D 7.27 -20,000 0
2020-12-15 2020-12-14 4 Weiss Lawrence Martin NEO Stock Option (Right to Buy) M - Exercise D 6.98 -50,000 0
2020-12-15 2020-12-14 4 Weiss Lawrence Martin NEO Common Stock S - Sale D 51.0600 -20,200 -1,031 100,521
2020-12-15 2020-12-14 4 Weiss Lawrence Martin NEO Common Stock M - Exercise D 19.6000 9,005 176 120,721
2020-12-15 2020-12-14 4 Weiss Lawrence Martin NEO Common Stock M - Exercise D 13.8700 16,666 231 111,716
2020-12-15 2020-12-14 4 Weiss Lawrence Martin NEO Common Stock M - Exercise D 9.2200 13,333 123 95,050
2020-12-15 2020-12-14 4 Weiss Lawrence Martin NEO Common Stock M - Exercise D 7.2700 20,000 145 81,717
2020-12-15 2020-12-14 4 Weiss Lawrence Martin NEO Common Stock M - Exercise D 6.9800 50,000 349 61,717
2020-03-03 2020-03-02 4 Weiss Lawrence Martin NEO Common Stock A - Award D 28.33 28.3300 37,514 1,063 37,514
2020-03-03 2020-03-02 4 Weiss Lawrence Martin NEO Common Stock A - Award D 5,824 11,717
2019-03-05 2019-03-01 4 Weiss Lawrence Martin NEO Stock Option (Right to Buy) A - Award D 19.60 19.6000 36,022 706 36,022
2019-03-05 2019-03-01 4 Weiss Lawrence Martin NEO Common Stock A - Award D 5,893 5,893
2018-12-14 2018-12-12 4 Weiss Lawrence Martin NEO Stock Option (Right to Buy) A - Award D 13.87 13.8700 25,000 347 25,000
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)